新闻
CANF
--
0.00%
--
Can-Fite to Present at The LD Micro 500 Virtual Conference on September 1, 2020
finviz · 08/26 11:00
微牛提供丰富的实时CANF股票新闻,让你可以通过多个平台了解CANF股票行情最新动态,这些免费的灿菲特生物制药新闻可以帮助你做出明智投资。
CANF 简况
Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company’s drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.
展开